173 related articles for article (PubMed ID: 36656424)
1. The Nutritional Intervention Improves the Metabolic Profile of Overweight and Obese PCOS Along with the Differences in Gut Microbiota.
Fu L; Li Y; Bian Y; Wang Q; Li J; Wang Y; Zhang T; Zou X; Cui L; Chen Z
Reprod Sci; 2023 Jul; 30(7):2210-2218. PubMed ID: 36656424
[TBL] [Abstract][Full Text] [Related]
2. Effects of three medical nutrition therapies on nutritional metabolism and intestinal flora in overweight/obese with polycystic ovary syndrome (PCOS): Study protocol for a randomised controlled trial.
Dou P; Zhuang ZH; Zhao YM; Yang YX; Zhang TT; Xu Y; Xue Q; Huang T
Asia Pac J Clin Nutr; 2023; 32(1):33-39. PubMed ID: 36997483
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome.
Eyupoglu ND; Ergunay K; Acikgoz A; Akyon Y; Yilmaz E; Yildiz BO
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32860695
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
5. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Khatlani K; Njike V; Costales VC
Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
[TBL] [Abstract][Full Text] [Related]
6. High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota.
Wang X; Xu T; Liu R; Wu G; Gu L; Zhang Y; Zhang F; Fu H; Ling Y; Wei X; Luo Y; Shen J; Zhao L; Peng Y; Zhang C; Ding X
Front Endocrinol (Lausanne); 2021; 12():806331. PubMed ID: 35185786
[TBL] [Abstract][Full Text] [Related]
7. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
Zhang J; Xing C; Cheng X; He B
Front Endocrinol (Lausanne); 2022; 13():1003238. PubMed ID: 36147577
[TBL] [Abstract][Full Text] [Related]
8. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Katsikis I
Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
[TBL] [Abstract][Full Text] [Related]
9. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.
Koiou E; Tziomalos K; Katsikis I; Kandaraki EA; Kalaitzakis E; Delkos D; Vosnakis C; Panidis D
Gynecol Endocrinol; 2012 Jan; 28(1):20-4. PubMed ID: 21756081
[TBL] [Abstract][Full Text] [Related]
10. Exploring the role of gut microbiota in obesity and PCOS: Current updates and future prospects.
Zhang H; Butoyi C; Yuan G; Jia J
Diabetes Res Clin Pract; 2023 Aug; 202():110781. PubMed ID: 37331521
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle Intervention for Overweight/Obese Pregnant Women with Polycystic Ovarian Syndrome: Lessons and Challenges.
Liu C; Zhang L; Zheng W; Liang X; Zhang L; Tian Z; Li G
Obes Facts; 2021; 14(4):405-414. PubMed ID: 34311460
[TBL] [Abstract][Full Text] [Related]
12. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
[TBL] [Abstract][Full Text] [Related]
13. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
[TBL] [Abstract][Full Text] [Related]
14. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
Jobira B; Frank DN; Silveira LJ; Pyle L; Kelsey MM; Garcia-Reyes Y; Robertson CE; Ir D; Nadeau KJ; Cree-Green M
PLoS One; 2021; 16(1):e0245219. PubMed ID: 33465100
[TBL] [Abstract][Full Text] [Related]
16. Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota.
Jobira B; Frank DN; Pyle L; Silveira LJ; Kelsey MM; Garcia-Reyes Y; Robertson CE; Ir D; Nadeau KJ; Cree-Green M
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2134-44. PubMed ID: 31970418
[TBL] [Abstract][Full Text] [Related]
17. Usage of mobile health interventions among overweight/obese PCOS patients undergoing assisted reproductive technology treatment during the COVID-19 pandemic.
Sang M; Wu Q; Tao Y; Huang F; Lu L; Zhou W; Li A; Bai S
Gynecol Endocrinol; 2022 Sep; 38(9):776-780. PubMed ID: 35993296
[No Abstract] [Full Text] [Related]
18. Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
Shishehgar F; Mirmiran P; Rahmati M; Tohidi M; Ramezani Tehrani F
BMC Endocr Disord; 2019 Sep; 19(1):93. PubMed ID: 31477085
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of aerobic exercise versus Yi Jin Jing on ovarian function in young overweight/obese women with polycystic ovary syndrome: study protocol for a randomized controlled trial.
Zhao J; Ketlhoafetse A; Liu X; Cao Y
Trials; 2022 Jun; 23(1):459. PubMed ID: 35658926
[TBL] [Abstract][Full Text] [Related]
20. Increased fibre and reduced trans fatty acid intake are primary predictors of metabolic improvement in overweight polycystic ovary syndrome-Substudy of randomized trial between diet, exercise and diet plus exercise for weight control.
Nybacka Å; Hellström PM; Hirschberg AL
Clin Endocrinol (Oxf); 2017 Dec; 87(6):680-688. PubMed ID: 28727165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
